Triple-Negative Breast Cancer Brain Mets


Y. Mahamodhossen et al  Triple-Negative Breast Cancer: New Perspectives for Novel Therapies  Med Oncol 2013 Sep:30(3):653

C. Erten et al  Cisplatin Plus Gemcitabine for Treament of Breast Cancer Patients with Brain Metastases; a Preferential option for Triple Negative Patients? Asian Pac J Cancer  2013;14(60):3711-7

D. Yamamoto et al  Bevacizumab in the Treatment of Five Patients with Breast Cancer and Brain Metastases: Japan Breast Cancer Research Network-07 Trial  Onco Targets There 2012;5:185-189 Asian Pac J Cancer Prev 2013;14(6):3711-7

R. Konigsberg et al  Tumor Characteristics and Recurrence Patterns in Triple Negative Breast Cancer: A Comparison between Younger and Elderly (65 or greater) Patients  Eur J Cancer 2012 Nov 48(16):2962-68 Epub 2012 May 28  

C. Nieder  Prediction of Short Survival in Patients with Brain Metastases Based on Three Different Scores: A Role for Triple-Negative Status? Clin Oncol (R Coll Radiol) Feb 2010 22(1):65-69

B. Pestalozzi  Brain Metastases and Subtypes of Breast Cancer  Annals of Oncology April 2009 20(4): 803-5 (free full text)

S. Dawood  et al  Survival among Women with Triple Receptor-Negative Breast Cancer and Brain Metastases  Annals of Oncology April 2009 20(4):621-7 (free full text)

N. Lin et al  Sites of Distant Recurrence and Clinical Outcome in Patients with Metastatic Triple-Negative Breast Cancer: High Incidence of Central Nervous System Metastases Cancer Nov 15, 2008 113(10):2638-45

B. Nam, S. Kim, J. Ro et al Breast Cancer Subtypes and Survival in Patients with Brain Metastases   Breast Cancer Research, Feb. 28, 2008

M. Melisko, D. Moore, H. Rugo et al Brain Metastases in Breast Cancer: Clinical and Pathologic Characteristics Associated with Improvements in Survival   Journal of Neurooncology. 2008; 88:359-365

S. Fromm, R. Bartsch, K. Dieckmann et al  Factors Influencing the Time to Development of Brain Metastases in Breast Cancer   The Breast,  2008; 1-5

Y. Than, K. Sexton, R. Elledge et al Primary Breast Cancer Phenotypes Associated with Propensity for Central Nervous System Metastases   Cancer,  July 2006

D. Hicks, S. Short, R. Weill et al  Breast Cancers with Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress Her2 or EGFR   American Journal of Surgery and Pathology, Sept. 26, 2006; 30:9